Search
for
Sort by
Research 30 of 59
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Ethanol extract of the freshwater green alga Prasiola japonica attenuates hair loss and promotes hair growth in a testosterone-induced hair loss model
- Forsythiasides: A review of the pharmacological effects
- Regulatory T Cells: the Many Faces of Foxp3
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Biological therapy in the treatment of melanoma
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Licorice: A review on phytochemical insights and therapeutic potential
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Regulatory T cells in inflammatory skin disease: from mice to humans
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections